BackReviva Pharmaceuticals Holdings Overview
Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Discounted Cash Flow

DCF Analysis for RVPH.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$0.39

Current Fair Value

$0.39
43.1% Downside

Overvalued by 43.1% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading